Advertisement

Acta Parasitologica

, Volume 64, Issue 3, pp 471–478 | Cite as

Antigenic Epitope Analysis and Efficacy Evaluation of GRA41 DNA Vaccine Against T. gondii Infection

  • Jian Zhou
  • Chenxi Li
  • Yingquan LuoEmail author
  • Lin WangEmail author
Original Paper
  • 44 Downloads

Abstract

Background

Toxoplasma gondii has a comprehensive impact on a great range of warm-blood mammals, in which one-third of the population all over the world is involved. Dense granular proteins, regarded as GRA family, mediating substantial interface between host cell cytoplasm and parasite, are widely studied for preventing the infection of T. gondii.

Purpose

As is handled in our study, the effect of intramuscularly injecting the genetic vaccine pEGFP-C1/GRA41 encoding a novel dense granule protein, GRA41, was evaluated.

Methods

At the beginning, bioinformatics analysis was used to evaluate epitopes of both B cells and T cells on the GRA41 protein of T. gondii. Afterwards, recombinant plasmids (pEGFP-C1/GRA41) were injected into BALB/c mice and the quantity of IgG and its subclass IgG2a remarkably increased. IFN-γ, distinctive from the other cytokines (IL-4, and IL-10), was significant in growth. Afterwards, the intraperitoneal challenge was executed for recording survival time with tachyzoites with high virulence (in RH strain) and counting the number of brain cysts was carried out after the infection of PRU strain (low virulence).

Results

In pEGFP-C1/GRA41 group, the survival period was significantly longer (13.3 ± 3.37 days) after tachyzoites attack with the RH strain in high virulence, compared with the other groups (less than 8 days). Additionally, the cyst quantity is remarkably lower and the rate of reduction could reach 59.34%.

Conclusion

All the results indicated effective protection of DNA vaccine encoding GRA41 against T. gondii.

Keywords

GRA41 Toxoplasma gondii Recombinant plasmids Vaccine Bioinformatics analysis 

Notes

Author Contributions

JZ and LW conceived and designed the study. JZ, CL and YL carried out the experiments and drafted the manuscript.

Funding

This work was supported by the Mittal Innovation Project of Central South University, the Fundamental Research Funds for the Central Universities of Central South University (Grant No. 2018zzts930), the Central South University Sports Medicine Scholarship, the National College Students’ Innovation and Entrepreneurship Training Program (Grant No. 201710422116).

Compliance with Ethical Standards

Conflict of Interest

We proclaim that there is no conflict of interests in the study and publication.

Ethics statement

Complying with Contract 2011–0015, we carried our study under the Institutional Animal Care and Use Committee of Shandong University. All the animals in our study were raised under protocols and approvals of Ethics Committee. As for sacrifices, the mice underwent euthanasia for humane endpoints and every step was designed to minimize suffering.

References

  1. 1.
    Ahmadpour E, Sarvi S, Hashemi SM, Sharif M, Rahimi MT, Valadan R, Tehrani M, Khalilian A, Montazeri M, Daryani A (2017) Evaluation of the immune response in BALB/c mice induced by a novel DNA vaccine expressing GRA14 against Toxoplasma gondii. Parasite Immunol 39(4):e12419.  https://doi.org/10.1111/pim.12419 CrossRefGoogle Scholar
  2. 2.
    Begeman IJ, Lykins J, Zhou Y, Lai BS, Levigne P, El BK, Boyer K, Withers S, Clouser F, Noble AG, Rabiah P, Swisher CN, Heydemann PT, Contopoulos-Ioannidis DG, Montoya JG, Maldonado Y, Ramirez R, Press C, Stillwaggon E, Peyron F, McLeod R (2017) Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries. PLoS Negl Trop Dis 11:e0005670.  https://doi.org/10.1371/journal.pntd.0005670 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Dominguez MF, Gonzalez-Miguel J, Carmona C, Dalton JP, Cwiklinski K, Tort J, Siles-Lucas M (2018) Low allelic diversity in vaccine candidates genes from different locations sustain hope for Fasciola hepatica immunization. Vet Parasitol 258:46–52.  https://doi.org/10.1016/j.vetpar.2018.06.011 CrossRefPubMedGoogle Scholar
  4. 4.
    Dong H, Su R, Lu Y, Wang M, Liu J, Jian F, Yang Y (2018) Prevalence, risk factors, and genotypes of Toxoplasma gondii in food animals and humans (2000–2017) from China. Front Microbiol 9:2108.  https://doi.org/10.3389/fmicb.2018.02108 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Dupont CD, Christian DA, Hunter CA (2012) Immune response and immunopathology during toxoplasmosis. Semin Immunopathol 34:793–813.  https://doi.org/10.1007/s00281-012-0339-3 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Foroutan M, Zaki L, Ghaffarifar F (2018) Recent progress in microneme-based vaccines development against Toxoplasma gondii. Clin Exp Vaccine Res 7:93–103.  https://doi.org/10.7774/cevr.2018.7.2.93 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Han Y, Zhou A, Lu G, Zhao G, Sha W, Wang L, Guo J, Zhou J, Zhou H, Cong H, He S (2017) DNA vaccines encoding Toxoplasma gondii cathepsin C1 induce protection against toxoplasmosis in mice. Korean J Parasitol 55:505–512.  https://doi.org/10.3347/kjp.2017.55.5.505 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Iyer SS, Cheng G (2012) Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol 32(1):23–63.  https://doi.org/10.1615/CritRevImmunol.v32.i1.30 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Jongert E, de Craeye S, Dewit J, Huygen K (2007) GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Parasite Immunol 29:445–453.  https://doi.org/10.1111/j.1365-3024.2007.00961.x CrossRefPubMedGoogle Scholar
  10. 10.
    Kang H, Remington JS, Suzuki Y (2000) Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase. J Immunol 164(5):2629–2634.  https://doi.org/10.4049/jimmunol.164.5.2629 CrossRefPubMedGoogle Scholar
  11. 11.
    LaFavers KA, Márquez-Nogueras KM, Coppens I, Moreno SNJ, Arrizabalaga G (2017) A novel dense granule protein, GRA41, regulates timing of egress and calcium sensitivity in Toxoplasma gondii. Cell Microbiol.  https://doi.org/10.1111/cmi.12749 CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Li Y, Zhou H (2018) Moving towards improved vaccines for Toxoplasma gondii. Expert Opin Biol Ther 18:273–280.  https://doi.org/10.1080/14712598.2018.1413086 CrossRefPubMedGoogle Scholar
  13. 13.
    Liu Q, Wang ZD, Huang SY, Zhu XQ (2015) Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors 8:292.  https://doi.org/10.1186/s13071-015-0902-6 CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Liu Y, Cao A, Li Y, Li X, Cong H, He S, Zhou H (2017) Immunization with a DNA vaccine encoding Toxoplasma gondii superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice. BMC Infect Dis 17:403.  https://doi.org/10.1186/s12879-017-2507-5 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Lu G, Zhou J, Zhao YH, Wang L (2018) DNA vaccine ROP29 from Toxoplasma gondii containing R848 enhances protective immunity in mice. Parasite Immunol 40(10):e12578.  https://doi.org/10.1111/pim.12578 CrossRefPubMedGoogle Scholar
  16. 16.
    Lu G, Zhou J, Zhou A, Han Y, Guo J, Song P, Zhou H, Cong H, Hou M, Wang L, He S (2017) SAG5B and SAG5C combined vaccine protects mice against Toxoplasma gondii infection. Parasitol Int 66:596–602.  https://doi.org/10.1016/j.parint.2017.06.002 CrossRefPubMedGoogle Scholar
  17. 17.
    Mercier C, Dubremetz JF, Rauscher B, Lecordier L, Sibley LD, Cesbron-Delauw MF (2002) Biogenesis of nanotubular network in Toxoplasma parasitophorous vacuole induced by parasite proteins. Mol Biol Cell 13:2397–2409.  https://doi.org/10.1091/mbc.e02-01-0021 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Ohshima J, Sasai M, Liu J, Yamashita K, Ma JS, Lee Y, Bando H, Howard JC, Ebisu S, Hayashi M, Takeda K, Standley DM, Frickel EM, Yamamoto M (2015) RabGDIalpha is a negative regulator of interferon-gamma-inducible GTPase-dependent cell-autonomous immunity to Toxoplasma gondii. Proc Natl Acad Sci USA 112:E4581–E4590.  https://doi.org/10.1073/pnas.1510031112 CrossRefPubMedGoogle Scholar
  19. 19.
    Quan JH, Chu JQ, Ismail HA, Zhou W, Jo EK, Cha GH, Lee YH (2012) Induction of protective immune responses by a multiantigenic DNA vaccine encoding GRA7 and ROP1 of Toxoplasma gondii. Clin Vaccine Immunol 19:666–674.  https://doi.org/10.1128/CVI.05385-11 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Robert-Gangneux F, Darde ML (2012) Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 25:264–296.  https://doi.org/10.1128/CMR.05013-11 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Scorza T, D’Souza S, Laloup M, Dewit J, De Braekeleer J, Verschueren H, Vercammen M, Huygen K, Jongert E (2003) A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection. Infect Immun 71:309–316.  https://doi.org/10.1128/iai.71.1.309-316.2003 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Sibley LD, Niesman IR, Parmley SF, Cesbron-Delauw MF (1995) Regulated secretion of multi-lamellar vesicles leads to formation of a tubulo-vesicular network in host-cell vacuoles occupied by Toxoplasma gondii. J Cell Sci 108(Pt 4):1669–1677PubMedGoogle Scholar
  23. 23.
    Sun XM, Zou J, Elashram Saeed AA, Yan WC, Liu XY, Suo X, Wang H, Chen QJ (2011) DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice. Parasit Vectors 4:213.  https://doi.org/10.1186/1756-3305-4-213 CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Wang Y, Yin H (2014) Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii. Parasit Vectors 7:180.  https://doi.org/10.1186/1756-3305-7-180 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Wisniewski M, Jaros S, Baska P, Cappello M, Dlugosz E, Wedrychowicz H (2016) Hamsters vaccinated with Ace-mep-7 DNA vaccine produced protective immunity against Ancylostoma ceylanicum infection. Exp Parasitol 163:1–7.  https://doi.org/10.1016/j.exppara.2016.01.006 CrossRefPubMedGoogle Scholar
  26. 26.
    Zhou J, Lu G, Wang L, Zhou AH, Han YL, Guo JJ, Song PX, Zhou HY, Cong H, Hou M, He SY (2017) Structuraland antigenic analysis of a new rhoptry pseudokinase gene (ROP54) in Toxoplasma gondii. Acta Parasitol 62:513–519.  https://doi.org/10.1515/ap-2017-0061 CrossRefPubMedGoogle Scholar
  27. 27.
    Zhou J, Wang L, Lu G, Zhou A, Zhu M, Li Q, Wang Z, Arken M, Wang A, He S (2016) Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii. Parasite 23:17.  https://doi.org/10.1051/parasite/2016017 CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Zhou J, Wang W, Song P, Wang L, Han Y, Guo J, Hao Z, Zhu X, Zhou Q, Du X, Lu G, He S, Luo Y (2018) Structural predication and antigenic analysis of Toxoplasma gondii ROP20. Acta Parasitol 63:244–251.  https://doi.org/10.1515/ap-2018-0028 CrossRefPubMedGoogle Scholar
  29. 29.
    Zhou J, Wang L (2017) SAG4 DNA and peptide vaccination provides partial protection against T. gondii infection in BALB/c mice. Front Microbiol 8:1733.  https://doi.org/10.3389/fmicb.2017.01733 CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Zhu WN, Wang JL, Chen K, Yue DM, Zhang XX, Huang SY, Zhu XQ (2017) Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice. Exp Parasitol 179:20–27.  https://doi.org/10.1016/j.exppara.2017.06.002 CrossRefPubMedGoogle Scholar

Copyright information

© Witold Stefański Institute of Parasitology, Polish Academy of Sciences 2019

Authors and Affiliations

  1. 1.Department of Orthopedics, The Second Xiangya HospitalCentral South UniversityChangshaChina
  2. 2.Center for Reproductive MedicineShandong UniversityJinanChina
  3. 3.Department of Clinical Medicine, School of MedicineShandong UniversityJinanChina
  4. 4.Department of Geriatrics, The Second Xiangya HospitalCentral South UniversityChangshaChina
  5. 5.Department of ElectroneurophysiologyJinan Children’s HospitalJinanChina

Personalised recommendations